UM Professor named Scientific Director of CIHR Institute of Infection and Immunity
Dr. Titus Olukitibi, a Postdoctoral Fellow in the lab, received the Nigerian Professionals in Manitoba (NPIM) Research, Innovation and Creativity Award.
Dr. Keith Fowke received the 2026 Mark Wainberg Award and gave a lecture during the CAHR conference in Winnipeg to honour the voice of fighting HIV
Dr. Keith Fowke received the 2025 James House Memorial Postdoctoral Mentorship Award
UM partner clinics in Nairobi fear for HIV patients after Trump’s freeze on foreign aid
New UM Banting fellow to address global public health inequity
Aspirin News: HIV discovery offers hope as cases hit historic highs
A quiet immune system could hold the key to preventing HIV
SPELBEC-Science 2025 grows in reach and impact Students spell success through science, mentorship and hands-on experiments
UM receives $57 million for vaccine and biomedical research and infrastructure
A science story of giving
PhD student champions youth participation on global health stage
The Faculty of Graduate Studies Hosts Three-Minute-Postdoc Competition – Winners Announced!
Rady HIV-AIDS researcher, educator receives inaugural postdoc fellowship in memory of AIDS trailblazer
40th Anniversary: Collaboration with University of Nairobi
Aspirin Project
For more information, click here
3MT winner dedicates award to research labA student who is working with an international team of researchers to understand the link between a birth control drug and HIV infection impressed a prestigious panel of judges at the eighth annual University of Manitoba Three Minute Thesis finals on June 3, 2020, winning first place and taking home the Dr. Archie McNichol Prize. The competition had been delayed following the onset of the COVID-19 pandemic.
|
Grand Challenges CanadaSome rare individuals are resistant to HIV infection; their immune system have a phenotype called immune quiescence (IQ). We propose to induce IQ in highly susceptible women by using low cost anti-inflammatory drugs to reduce HIV incidence by 30%. This project is a recipient of the Stars in Global Health Phase I award. For more information, click here.
|







